Published in Aust N Z J Surg on August 01, 1971
In situ localization of C3 synthesis in experimental acute renal allograft rejection. Am J Pathol (2000) 1.12
Blockade of T-lymphocyte KCa3.1 and Kv1.3 channels as novel immunosuppression strategy to prevent kidney allograft rejection. Transplant Proc (2009) 1.02
Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia/reperfusion damage, acute rejection, and chronic nephropathy. Am J Pathol (2003) 0.97
Specific cytotoxic T cells are found in the nonrejected kidneys of blood-transfused rats. J Exp Med (1987) 0.95
Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat. Am J Pathol (1996) 0.93
The role of subregions of the rat major histocompatibility complex in the rejection and passive enhancement of renal allografts. J Exp Med (1979) 0.81
Kidney-specific alloantigen system in the rat. Characterization and role in transplantation. J Exp Med (1980) 0.81
Functional role of thromboxane production by acutely rejecting renal allografts in rats. J Clin Invest (1985) 0.80
Dimethylarginine metabolism during acute and chronic rejection of rat renal allografts. Nephrol Dial Transplant (2010) 0.78
Investigation of the mechanism of active enhancement of renal allograft survival by blood transfusion. Immunology (1988) 0.77
The combined use of antilymphocyte serum and cyclophosphamide to suppress renal allograft rejection in the rat. Clin Exp Immunol (1979) 0.77
Monocytic Tissue Transglutaminase in a Rat Model for Reversible Acute Rejection and Chronic Renal Allograft Injury. Mediators Inflamm (2015) 0.77
Histocompatibility in organ transplantation. Ann R Coll Surg Engl (1973) 0.75
Hepcidin as a Biomarker of Impaired Renal Function in Rat Models for Chronic Allograft Nephropathy. Med Sci Monit (2016) 0.75
Expression of acetylcholine receptors by experimental rat renal allografts. Biomed Res Int (2014) 0.75
Hematopoietic cell transplantation for tolerance induction. Cytotechnology (1998) 0.75
Donor B cells in splenic follicles of experimental pulmonary allograft recipients. Langenbecks Arch Surg (2007) 0.75
Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens (1995) 6.33
Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med (1990) 4.48
Legionnaires' disease in a transplant unit: isolation of the causative agent from shower baths. Lancet (1980) 4.04
Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J Exp Med (1990) 3.73
"Hyperacute" renal-homograft rejection in man. N Engl J Med (1968) 3.37
Counseling parents about childhood discipline. Am Fam Physician (1992) 3.29
Organisation of vascular surgical services: evolution or revolution? BMJ (1994) 3.28
IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol (2001) 3.22
Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J Exp Med (1995) 3.16
Migration patterns of dendritic cells in the mouse. Homing to T cell-dependent areas of spleen, and binding within marginal zone. J Exp Med (1988) 2.98
Migration patterns of dendritic cells in the mouse. Traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissues. J Exp Med (1988) 2.73
Association of autoimmune active chronic hepatitis with HL-A1,8. Lancet (1972) 2.69
Urological complications in 1,000 consecutive renal transplant recipients. J Urol (1995) 2.48
The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation (1984) 2.45
The survival of patients with colorectal cancer treated in a regional hospital. Br J Surg (1978) 2.27
The detailed distribution of MHC Class II antigens in normal human organs. Transplantation (1984) 2.26
Systemic cytokine response after major surgery. Br J Surg (1992) 2.23
Studies on the immunosuppressive properties of cyclosporin a in rats receiving renal allografts. Transplantation (1980) 2.21
Preservation solutions for static cold storage of kidney allografts: a systematic review and meta-analysis. Am J Transplant (2012) 2.18
Surgical management of the thoracic outlet compression syndrome. Br J Surg (1991) 2.13
Interactive effect of Gm allotypes and HLA-B locus antigens on the human antibody response to a bacterial antigen. Clin Exp Immunol (1980) 2.12
A randomized controlled trial comparing the hair apposition technique with tissue glue to standard suturing in scalp lacerations (HAT study). Ann Emerg Med (2002) 2.06
The effects of fasting in Muslim patients taking warfarin. J Thromb Haemost (2014) 2.06
Carotid endarterectomy in Great Britain and Ireland. Br J Surg (1986) 1.90
Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type. Diabetes (1977) 1.88
Isolation of rat pancreatic islets by ductal injection of collagenase. Transplantation (1986) 1.88
A mixed culture recovery method indicates that enteric bacteria do not enter the viable but nonculturable state. Appl Environ Microbiol (1998) 1.85
Pancreaticoduodenal cancer. Experience from 1951 to 1960 with a look ahead and behind. Arch Surg (1966) 1.83
Cyclosporin A. Transplantation (1981) 1.72
Provision of vascular surgical services in the Oxford Region. Br J Surg (1994) 1.65
Recovery of hydrogen peroxide-sensitive culturable cells of Vibrio vulnificus gives the appearance of resuscitation from a viable but nonculturable state. J Bacteriol (2000) 1.63
Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med (1991) 1.62
A method for isolation of islets of Langerhans from the human pancreas. Diabetes (1984) 1.60
Randomised double-blind trial of quinine sulphate for nocturnal leg cramp. Br J Clin Pract (1986) 1.59
Distribution and quantitation of HLA-ABC and DR (Ia) antigens on human kidney and other tissues. Transplantation (1980) 1.59
Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor-specific transfusion and anti-CD4 antibody. Evidence of a clear role for short-term antigen persistence. Transplantation (1995) 1.58
myo-inositol pentakisphosphates. Structure, biological occurrence and phosphorylation to myo-inositol hexakisphosphate. Biochem J (1991) 1.57
Is hypertension associated with hemifacial spasm? Neurology (2003) 1.56
Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet (1996) 1.54
Long-term follow-up after weight management in obese dogs: the role of diet in preventing regain. Vet J (2011) 1.53
Genetic susceptibility to the development of retinopathy in insulin-dependent diabetics. Diabetes (1982) 1.53
The effect of smoking on the late patency of arterial reconstructions in the legs. Br J Surg (1978) 1.51
Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. Eur J Vasc Endovasc Surg (1996) 1.51
Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation (2004) 1.51
The mortality of abdominal aortic aneurysm. Ann R Coll Surg Engl (1986) 1.50
T cell activation by anti-T3 antibodies: comparison of IgG1 and IgG2b switch variants and direct evidence for accessory function of macrophage Fc receptors. Eur J Immunol (1986) 1.49
The urological complications of renal transplantation: a series of 1535 patients. BJU Int (2002) 1.48
Upper gastrointestinal haemorrhage in Oxford. A prospective study. J R Coll Surg Edinb (1984) 1.48
Persistence of sisomicin and gentamicin in renal cortex and medulla compared with other organs and serum of rats. Kidney Int (1976) 1.48
Death of the Escherichia coli K-12 strain W3110 in soil and water. Appl Environ Microbiol (1996) 1.46
Elective ventilation of potential organ donors. BMJ (1995) 1.45
Portal endotoxin and cytokine responses during abdominal aortic surgery. Am J Surg (1993) 1.45
Differential response in a patient treated with Campath-1H monoclonal antibody for refractory non-Hodgkin lymphoma. Lancet (1993) 1.44
Cefoperazone: pharmacokinetics in humans with normal and impaired renal function and pharmacokinetics in rats. Clin Ther (1980) 1.44
Effector mechanisms in allograft rejection. Annu Rev Immunol (1986) 1.43
Role of transplantation in the management of hepatic malignancy. Br J Surg (2007) 1.40
Carotid duplex scanning: patterns of referral and outcome. Eur J Vasc Endovasc Surg (1995) 1.40
The effect of donor strain blood pretreatment on renal allograft rejection in rats. Transplantation (1972) 1.40
Isolation and characterization of dendritic cells from mouse heart and kidney. J Immunol (1994) 1.40
Auditing the vascular surgical audit. Br J Surg (1987) 1.39
Paraplegia caused by spinal infection after acupuncture. Spinal Cord (2006) 1.39
Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". Eur J Vasc Endovasc Surg (2011) 1.38
Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients. Transplantation (1994) 1.37
Localization of major histocompatibility complex (HLA-ABC and DR) antigens in 46 kidneys. Differences in HLA-DR staining of tubules among kidneys. Transplantation (1983) 1.32
Carotid endarterectomy in Great Britain and Ireland: practice between 1984 and 1992. Br J Surg (1994) 1.31
A technique for lymphocyte preparation from stored heparinized blood. Vox Sang (1971) 1.31
Developments in isolated pancreatic islet transplantation. Transplantation (1987) 1.30
Renal failure, drug pharmacokinetics and drug action. Clin Pharmacokinet (1976) 1.29
Wound dehiscence. A continuing problem in abdominal surgery. Arch Surg (1966) 1.29
Matching for HLA in transplantation. Br Med Bull (1978) 1.27
Distribution and excretion of doxycycline in man. Chemotherapy (1966) 1.26
Trends in management of acute cholecystitis. Br Med J (Clin Res Ed) (1982) 1.25
Prediction of the clinical course of Behçet's colitis according to macroscopic classification by colonoscopy. Endoscopy (2000) 1.24
Urological complications in 600 consecutive renal transplants. Br J Surg (1987) 1.23
Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med (1991) 1.23
p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor. J Biol Chem (1999) 1.22
Organ donation in the UK: a survey by a British Transplantation Society working party. Nephrol Dial Transplant (1997) 1.21
Improvement in insulin resistance and reduction in plasma inflammatory adipokines after weight loss in obese dogs. Domest Anim Endocrinol (2009) 1.20
[Pharmacokinetics of a new cephalosporin, cefoperazone]. Schweiz Med Wochenschr (1979) 1.20
Pain after laparoscopic cholecystectomy: the effect and timing of incisional and intraperitoneal bupivacaine. Can J Anaesth (2001) 1.19
Localization of HLA-ABC and DR antigens in human kidney. Transplantation (1981) 1.19
HLA and pancreatic islet cell antibodies in diabetes. Lancet (1976) 1.18
Inability of dendritic cells to prevent the blood transfusion effect in a mouse cardiac allograft model. Transplantation (1987) 1.17
Muscle metabolism in patients with peripheral vascular disease investigated by 31P nuclear magnetic resonance spectroscopy. Clin Sci (Lond) (1986) 1.17
Quality of life is reduced in obese dogs but improves after successful weight loss. Vet J (2011) 1.16
Characterization of lymphocytotoxic antibodies causing a positive crossmatch in renal transplantation. Relationship to primary and regraft outcome. Transplantation (1989) 1.16
Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J Immunol (2001) 1.16
CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection. J Immunol (2000) 1.15
Effects of major and minor surgery on plasma glutamine and cytokine levels. Arch Surg (1992) 1.14
Letter: A possible association between paralytic poliomyelitis and multiple sclerosis. Lancet (1973) 1.14
Leucocyte antigens in Hodgkin's disease. Lancet (1970) 1.13
Cyclosporin conversion versus conventional immunosuppression: long-term follow-up and histological evaluation. Lancet (1987) 1.13
[Prognosis and development of myocardial infarct]. Schweiz Med Wochenschr (1965) 1.13
Segmental small intestinal allografts in the dog. I. Morphological and functional indices of rejection. Transplantation (1987) 1.13
Variation in expression of endothelial adhesion molecules in pretransplant and transplanted kidneys--correlation with intragraft events. Transplantation (1993) 1.12
SRF is a nuclear repressor of Smad3-mediated TGF-beta signaling. Oncogene (2006) 1.12
Mechanisms of allograft rejection: the roles of cytotoxic T-cells and delayed-type hypersensitivity. Immunol Rev (1984) 1.12
Immediate renal-graft biopsy and subsequent rejection. Lancet (1968) 1.12
[Complex pneumoconiosis in dental laboratory technicians]. Poumon Coeur (1978) 1.11
Serotyping for homotransplantation. XII. Occurrence of cytotoxic antibodies following kidney transplantation in man. Transplantation (1968) 1.11